A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
Status:
Recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
A Phase 3, randomized, placebo-controlled, double-masked, parallel study in healthy subjects.
It is designed to evaluate the ocular safety of a single topical ocular administration of
AG-920 sterile topical ophthalmic solution compared to placebo..